pioneer 8 semaglutide Dose-response, efficacy, and safety of oral monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial Summary of PIONEER 1-8 study

They identified nearly 70,000 users who said they were taking drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)

The stepwise dose escalation is there to help your body adjust to the medication, minimizing potential side effects while optimizing its effectiveness

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Like any medication, side effects are a reality: semaglutides can cause nausea, vomiting, diarrhea, kidney issues and potentially a thyroid tumor in susceptible people